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Abstract
Nocardia farcinica is one of the more recently identified species of the Nocardia genus. Nocardia farcinica keratitis is
a rare occurrence, with only eight previously reported cases. Semi-permeable rigid contact lens use was associated
with one of these reported cases. We report the first case of an extended wear soft contact lens-related Nocardia
farcinica keratitis and recommend a new treatment regime. A 47-year-old lady presented with a right eye keratitis
after wearing her extended wear soft contact lenses for five continuous weeks. There was no history of trauma or
swimming with contact lenses in. Empirical ciprofloxacin and tobramycin eye drops were not tolerated due to
ocular surface irritation on application, and instead, empirical treatment was with chloramphenicol and fortified
gentamicin 1.5 % eye drops. Corneal scrapings grew Nocardia farcinica after 3 weeks—sensitive to amikacin and
co-trimoxazole. Treatment was changed to amikacin 2.5 % eye drops, resulting in partial resolution of the corneal
infiltrates. Oral co-trimoxazole 160 mg/800 mg BD was added, due to cultured drug sensitivity and its high ocular
penetration, with good results and a final right eye best-corrected visual acuity of 6/5. Nocardia farcinica keratitis
should be considered in the differential diagnosis of contact lens-related keratitis. We report the first case occurring
in association with extended wear soft contact lenses. Nocardia species can mimic fungal and acanthamoeba
keratitis. Treatment with oral co-trimoxazole has not been previously reported. This case demonstrates the role of
co-trimoxazole in treating Nocardia farcinica keratitis based on cultured drug sensitivities.
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Introduction
Nocardia species (sp.) are a rare cause of human ocular
infections [1–8]. Advances in laboratory techniques have
resulted in further speciation of the genus [2, 3]. Nocar-
dia farcinica is a newer species and has been implicated
in keratitis, endophthalmitis, and chorioretinitis [1–6].
Eight cases of Nocardia farcinica keratitis have been
reported in the literature, and only one has been associ-
ated with contact lens wear (semi-permeable rigid
contact lenses) [1]. We report the first case of extended
wear soft contact lens-related Nocardia farcinica kera-
titis and recommend a new treatment regime.
Report
A 47-year-old Caucasian woman presented with a 2-day
history of a red, painful, photophobic right eye and
marked blepharospasm, on a background of contact lens
wear. She wore her monthly disposable soft contact lenses
for five continuous weeks. There was a history of recent
gardening, but no trauma, travel to remote areas, or swim-
ming while wearing contact lenses. Her only medication
was irbesartan for well-controlled hypertension.
On examination, unaided visual acuity in the right eye
at presentation was 6/18, improving to 6/9 with pinhole
correction. Best-corrected visual acuity (BCVA) in the
left eye was 6/9. The right eye was injected with four
central satellite lesions (Fig. 1) and moderate anterior
chamber reaction (cells 3+; flare 1+; no hypopyon). The
vitreous was quiet and intraocular pressure was
14 mmHg right eye. Ocular examination of the left eye
was unremarkable. Corneal scrapings were taken, and
her contact lenses were sent for microscopy, culture,
and sensitivities.
Treatment with ciprofloxacin 0.3 % eye drops hourly and
homatropine 2 % eye drops TDS right eye was commenced.
The patient was non-compliant due to ocular surface irrita-
tion from the drops. Antibiotic therapy was changed to
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tobramycin 0.3 % eye drops hourly right eye 2 days post-
presentation to improve compliance, but was again unsuc-
cessful due to irritation from the tobramycin. Four days
after presentation, treatment was changed to chloram-
phenicol minims hourly, fortified gentamicin 1.5 % eye
drops hourly, and atropine 1 % minims TDS right eye. Ocu-
lar surface discomfort settled on this treatment regime. Fur-
ther right eye corneal scraping was performed.
After 1 week of treatment, the right eye unaided visual
acuity reduced to light perception, improving to 6/18 with
pinhole correction. Corneal oedema and inferior keratic
precipitates had developed, and the satellite lesions had co-
alesced into a 4.7 mm× 3.8 mm wreath-like infiltrate with
surrounding stromal hyphae and a central corneal epithelial
defect. The posterior segment remained uninvolved. The
initial corneal scraping and contact lens cultures revealed
no pathogens. The second corneal scraping identified a
Gram-positive aerobic Actinomyces only. Treatment on
hourly chloramphenicol 0.3 % minims and gentamicin
1.5 % eye drops right eye continued until drug sensitivities
were available.
Following 3 weeks of culture, the second corneal scraping
grew Nocardia farcinica (Fig. 2)—sensitive to co-trimoxazole
and amikacin and resistant to cephalothin, tobramycin, and
ciprofloxacin. Sensitivities to chloramphenicol and gentami-
cin were not available from the laboratory.
Treatment with prednisolone acetate eye drops six times
per day right eye was commenced after fungal pathogens
were not cultured. The patient remained on hourly chlor-
amphenicol 0.3 % minims and gentamicin 1.5 % eye drops
for another 2 weeks. The keratitis remained stable in this
period, and the right eye pinhole vision fluctuated between
6/36 and 6/18. The wreath-like infiltrate and central epi-
thelial defect did not change in size, and the anterior
chamber reaction reduced slightly.
The antibiotic regime was subsequently changed to amika-
cin 2.5 % eye drops hourly right eye based on drug sensitiv-
ities. The patient remained on atropine 1 % minims TDS
and prednisolone acetate eye drops six times per day right
eye. Within 1 week on this regime, an improvement oc-
curred, with less conjunctival injection and decreased density
of the wreath-like infiltrate. However, the size of the infiltrate
and central epithelial defect showed no change. In consult-
ation with the Infectious Diseases Unit, oral co-trimoxazole
160 mg/800 mg BD (trimethoprim-sulfamethoxazole) was
added based on the cultured drug sensitivities and its high
ocular penetration [9]. Unfortunately, given the regional lo-
cation of the treating hospital, polymyxin B and trimetho-
prim ophthalmic solution was not available from the
pharmacy. The wreath-like infiltrate and epithelial defect re-
solved on this treatment regime over the subsequent 3
weeks, leaving a dense central corneal scar. The right eye
BCVA was now hand movements at 3 m. The amikacin
2.5 % eye drops were tapered weekly, prednisolone acetate
eye drops were increased to two hourly, and oral co-
trimoxazole 160 mg/800 mg BD and atropine 1 % eye drops
were ceased.
Clinical improvement occurred over the next month,
and the right eye pinhole vision was now 6/18. However,
Fig. 1 Satellite lesions at presentation
Fig. 2 a Gram stain of Nocardia farcinica showing Gram-positive rod-shaped bacteria. b Modified Ziehl-Neelsen stain showing partial
acid-fast reaction
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the patient reported 2 days of redness, ocular surface
discomfort, and photophobia whilst on amikacin 2.5 %
eye drops TDS and prednisolone acetate eye drops six
times per day. The right eye pinhole vision reduced to 6/
60. A new epithelial defect and satellite lesion had devel-
oped superior to the corneal scar (Fig. 3). Subsequently,
amikacin 2.5 % eye drops were increased to hourly, oral
co-trimoxazole 160 mg/800 mg BD was restarted, and
prednisolone acetate eye drops were ceased.
The new satellite lesion did not form a wreath-like infil-
trate as had occurred previously. The epithelial defect re-
quired 3 weeks of amikacin 2.5 % eye drops hourly right
eye and oral co-trimoxazole 160 mg/800 mg BD before
healing. Prednisolone acetate eye drops were continued by
the patient to relieve ocular discomfort against advice.
Once the epithelial defect had healed, oral co-trimoxazole
was ceased and amikacin eye drops were tapered.
Prednisolone acetate eye drops had been successfully
ceased, and there were no signs of relapse on the tapering
dose of amikacin eye drops over the course of the next
8 weeks. At the final review, right eye BCVA was 6/5 with a
faint central wreath-like anterior stromal scar and no anterior
chamber activity. Written consent was obtained from the pa-
tient for publication of this case report and any accompany-
ing images, provided no identifying features were released.
Discussion
Nocardia sp. are Gram-positive, partially acid-fast, aer-
obic rod-shaped bacteria that rarely cause systemic dis-
ease due to low virulence [1–8, 10]. Advances in
laboratory speciation techniques have lead to the discov-
ery of newer species, with identification of several other
Nocardia sp. capable of infiltrating the cornea [2, 3].
The discovery of Nocardia farcinica is important be-
cause of its resistance to several common topical oph-
thalmic antibiotics [1, 10–13].
Most reported cases of intraocular Nocardia farcinica
infection have occurred secondary to haematogenous
spread from a primary pulmonary infectious focus in im-
munocompromised individuals [3–6, 10]. There have been
two reported cases of post-operative and post-traumatic
endophthalmitis caused from Nocardia farcinica [5, 6].
The genus Nocardia are saprophytes [1–8, 10]. There
have been eight documented cases of Nocardia farcinica
keratitis [1, 2]. Seven of these cases were reported in a
South Indian study, and all occurred secondary to trauma
with organic matter [2]. The remaining case of Nocardia
farcinica keratitis was contact lens-related, occurring after
semi-permeable rigid contact lenses were cleaned in
unchlorinated rainwater [1]. We report the first case of
Nocardia farcinica keratitis occurring with the use of
extended wear soft contact lenses.
Extended wear soft contact lenses are a well docu-
mented major risk factor for microbial keratitis, due to
their interference with the natural defence properties of
the ocular surface [14]. It has not commonly been re-
ported as a cause of Nocardia sp. keratitis [1, 2, 15, 16].
However, the larger studies on Nocardia sp. keratitis have
been conducted in less urbanised areas, leaving the poten-
tial for population bias [2, 16]. Our case adds to the small
number of Nocardia sp. keratitis cases where contact lens
wear was the most likely predisposing factor [1, 15].
Nocardia sp. keratitis has been reported as presenting
with patchy anterior stromal infiltrates—occasionally with
feathery borders, stromal hyphae, and wreath-like infil-
trates [1, 2, 6, 15, 16]. Keratic precipitates and endothelial
ring deposits have also been documented [2]. The presen-
tation of this case was consistent with these reports but
was unusual as there was no history of contamination
with plant matter as has been described in other cases of
Nocardia farcinica keratitis [1, 2]. Nocardia sp. keratitis
mimics the presentation of fungal keratitis and could
mislead clinicians to commence empirical treatment with
antifungal therapy [1, 2, 15, 17].
Acanthamoeba keratitis is included in the differential
diagnosis of Nocardia farcinica keratitis, as both present
with marked blepharospasm, photophobia, and wreath-
like infiltrates [1, 2]. There has previously been one report
of Nocardia asteroides keratitis being successfully treated
with polyhexamethylene biguanide, demonstrating that
this pool disinfectant could be used as an empirical treat-
ment in Nocardia sp. keratitis [2, 15].
Ciprofloxacin 0.3 % eye drops are widely regarded
as an empirical treatment for contact lens-related
keratitis due to its efficacy against common causative
pathogens [14]. This patient was empirically treated
Fig. 3 Reactivation: new satellite lesion superior to the stromal scar
from the previous infection site
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with ciprofloxacin eye drops and then tobramycin eye
drops, another agent commonly used to treat contact lens
keratitis [14]. The strain of Nocardia farcinica grown from
this patient’s corneal scrapings was resistant to ciprofloxa-
cin and tobramycin. A South Indian study looking at the
antibiotic sensitivities of four different Nocardia sp.
(Nocardia asteroides, Nocardia farcinica, Nocardia cyria-
cigeorgica, Nocardia otitidiscaviarum) found that Norcar-
dia farcinica was the only species to display complete
resistance to gentamicin, tobramycin, and cefotaxime but
found that all seven cases were sensitive to ciprofloxacin
[18].
Previous reports have found a high level of resist-
ance in Nocardia farcinica to both chloramphenicol
and gentamicin [1, 16, 19, 20]. This highlights the im-
portance of testing sensitivities to all potential oph-
thalmic antibiotics, especially in atypical clinical
presentations. This is particularly relevant with Nocardia
farcinica, which is resistant to many common topical oph-
thalmic antibiotic preparations [1, 10, 11, 15–20]. There
have been no reports of amikacin resistance in Nocardia
farcinica [1, 2, 11, 12, 19, 21, 22]. There have been a few
reported cases in the general medical literature of Nocar-
dia farcinica resistance to co-trimoxazole [4, 10, 16, 17].
The role of systemic antibiotics in Nocardia sp. kera-
titis has not been documented [2, 16]. In this patient,
resolution of the epithelial defect and clearing of the
corneal infiltrates only occurred after commencement of
oral co-trimoxazole. The high ocular penetration and
minimal side effect profile of co-trimoxazole make it
beneficial as an adjunct to topical treatment in Nocardia
sp. keratitis, based on cultured drug sensitivities [9].
Clinical reactivation of infection occurred with topical
steroid use after the epithelial defect had commenced
scarring. Reactivation with steroid use in Nocardia sp.
keratitis has been documented before, and thus should
be used cautiously [1, 2].
Nocardia farcinica is a rare cause of keratitis and
should be considered as differential diagnoses of contact
lens-related keratitis, post-traumatic keratitis, and clin-
ical pictures suggestive of fungal and acanthamoeba
keratitis. This is the first reported case of Nocardia farci-
nica keratitis occurring secondary to extended wear soft
contact lenses. Nocardia sp. keratitis is a challenge to
treat empirically due to high levels of resistance to com-
mon topical ophthalmic antibiotics. Despite delayed
treatment in this case, the keratitis responded well to a
combination of amikacin 2.5 % eye drops, oral co-
trimoxazole 160 mg/800 mg BD and long duration of
therapy, with a final right eye BCVA of 6/5. This case
demonstrates the effectiveness of oral co-
trimoxazole160/800 mg BD in treating Nocardia farci-
nica keratitis, and we recommend considering it as an
adjunct treatment based on cultured drug sensitivities.
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